Clinical Trial Update: Study of Axial and Cognitive Symptoms and Biomarkers of Neurodegeneration in Brain-first and Body-first PD

View source ↗

Summary

A ClinicalTrials.gov study evaluating axial and cognitive symptoms and neurodegeneration biomarkers in brain-first and body-first Parkinson's disease; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Parkinsonism
• Synucleinopathies

Snippet

Sponsor: Azienda USL Reggio Emilia - IRCCS | Conditions: Parkinson Disease, Parkinsonian Disorders | Status: RECRUITING